Anticoagulation

ACC.24 Late-breaking Science Preview

Listen time: 28m 10s

Juan Carlos Diaz , Mauricio Duque , Jorge Marin , et al

Read time: 18m
EP 105: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Listen time: 1h 3m 40s
Parallax: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Watch time: 1h 5m 20s
CardioNerds @AHA23: ARTESiA: Stroke Risk Reduction in Sub-Clinical AF: Apixaban vs Aspirin

Naima Maqsood, Jeff Healey,

Watch time: 11m 15s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 23m 13s
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF

Naima Maqsood, Christian Ruff,

Watch time: 10m 36s
ESC 23: MULTISTARS AMI Trial

Linda Joosten,

Watch time: 4m 9s
ESC 23: The PUSH-AHF Study

Paulus Kirchhof,

Watch time: 3m 42s

Yugo Yamashita,

Early versus Later Anticoagulation for Stroke with Atrial Fibrillation

Else Sandset, Jesse Dawson , Urs Fischer, et al

Watch time: 28m

Brian Zenger , Scott Rizzi , Benjamin A Steinberg , et al

Read time: 20 Mins

Andreas Goette , Hein Heidbuchel ,

Georg Nickenig, Todd Villines, Christopher P Cannon, et al

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

Watch time: 4h 13m 20s (28 videos)

John JV McMurray, Mirvat Alasnag, Purvi Parwani, et al

Watch time: 4h 49m 46s (47 videos)

Pascal Vranckx , Marco Valgimigli , Hein Heidbuchel ,

George D Dangas, Adrian P Banning, Davide Cao, et al

Watch time: 3h 30m 28s (17 videos)

Yugo Yamashita,

Demosthenes G Katritsis , Bernard J Gersh , A John Camm ,

Katarzyna Dudzińska-Szczerba , Piotr Kułakowski , Ilona Michałowska , et al

ESC 23: The PUSH-AHF Study

Paulus Kirchhof,

Watch time: 3m 42s
ACC 22: Results from the PACIFIC AF Trial

Manesh R Patel,

Watch time: 3m 19s

Brian Zenger , Scott Rizzi , Benjamin A Steinberg , et al

Read time: 20 Mins

Media

View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 23m 13s
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF

Naima Maqsood, Christian Ruff,

Watch time: 10m 36s
ESC 23: MULTISTARS AMI Trial

Linda Joosten,

Watch time: 4m 9s
ESC 23: The PUSH-AHF Study

Paulus Kirchhof,

Watch time: 3m 42s

Yugo Yamashita,

ESC 22 Late-breaker Discussion: The INVICTUS Trial

Harriette Van Spall, Ganesan Karthikeyan,

Watch time: 17m 13s

Watch time: 3h 52m 31s
View from the Thoraxcenter: ACC.22 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 28m 6s

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

Watch time: 4h 13m 20s (28 videos)
ACC 22: Results from the PACIFIC AF Trial

Manesh R Patel,

Watch time: 3m 19s
View from the Thoraxcanter: ACC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 23m 9s
ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI

George D Dangas,

Watch time: 6m 33s

Media

ESC 23: MULTISTARS AMI Trial

Linda Joosten,

Watch time: 4m 9s
Parallax: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Watch time: 1h 5m 20s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 23m 13s

A John Camm, Paulus Kirchhof, Raffaele De Caterina, et al

HRS 2020: Incidence of Silent Brain Infarcts in Anticoagulated Patients with AF

David Conen,

Watch time: 7m 38s

Yugo Yamashita,

CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF

Naima Maqsood, Christian Ruff,

Watch time: 10m 36s
CardioNerds @AHA23: ARTESiA: Stroke Risk Reduction in Sub-Clinical AF: Apixaban vs Aspirin

Naima Maqsood, Jeff Healey,

Watch time: 11m 15s
ESC 23: The PUSH-AHF Study

Paulus Kirchhof,

Watch time: 3m 42s

John JV McMurray, Mirvat Alasnag, Purvi Parwani, et al

Watch time: 4h 49m 46s (47 videos)

Watch time: 3h 52m 31s

Gheorghe-Andrei Dan,

Watch time: 1h 12m 28s

Articles

Individualising Anticoagulant Therapy in Atrial Fibrillation Patients

Marco Alings

,

Citation:

Arrhythmia & Electrophysiology Review 2016;5(2):102–9

DOI:

https://doi.org/10.15420/aer.20.3
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1995
  • Downloads: Downloads 13
  • Read time: 30m

Anticoagulation in Atrial Fibrillation – Current Concepts

Demosthenes G Katritsis

,

Bernard J Gersh

,

A John Camm

,

Citation:

Arrhythmia & Electrophysiology Review 2015;4(2):100–7

DOI:

https://doi.org/10.15420/aer.2015.04.02.100
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 3437
  • Downloads: Downloads 19
  • Citations: 12

Optimal Anticoagulation Strategy for Cardioversion in Atrial Fibrillation

Philipp Bushoven

,

Sven Linzbach

,

Mate Vamos

,

Stefan H Hohnloser

,

Citation:

Arrhythmia & Electrophysiology Review 2015;4(1):44-6

DOI:

https://doi.org/10.15420/aer.2015.4.1.44
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 2074
  • Downloads: Downloads 4
  • Citations: 2

The European Heart Rhythm Association Practical Guide on the Use of New Oral Anticoagulants in Patients with Non-valvular Atrial Fibrillation - A Brief Summary

Katrina Mountfort

,

Citation:

Arrhythmia & Electrophysiology Review 2013;2(2):115-9

DOI:

https://doi.org/10.15420/aer.2013.2.2.115
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 982
  • Downloads: Downloads 7
  • Citations: 1